article thumbnail

PicnicHealth Acquires AllStripes, Fortifying its Role as the Leader in Patient-Centered Healthcare Evidence Generation

Healthcare IT Today

This strategic consolidation establishes PicnicHealth as the leading patient-centric evidence-generation partner within a rapidly evolving life sciences landscape. By combining forces, we can unlock the potential of patient-centered studies and provide best-in-class solutions to support therapeutic development.”

article thumbnail

Debiopharm Innovation Fund Launches New Seed Funding Activity to Accelerate Digital Transformation of Cancer Care and Pharma R&D

Digital Health Global

Investments will focus on the next generation of pharma R&D to accelerate drug development, on new technology solutions enabling a more patient-centric approach in clinical trials, and on digital platforms uncovering new insights from clinical data for more personalized care pathways.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Genomics Startup Human Longevity’s Valuation Falls 80% from $1.6 Billion down to $310M

Lloyd Price

billion valuation in the last fundraising in early 2017, according to Lagniappe. Life-sciences companies recorded the strongest gains, Fenwick found, with their valuations rising 110% compared with their prior funding rounds. But key facets of its business didn’t develop as planned, say people familiar with the company.

article thumbnail

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Digital Health Global

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

article thumbnail

Blockchain in Healthcare: A Vehicle Towards Digital Health 2.0?

The Digital Health Corner

Blockchain technology’s potential impact on the life sciences industry (drug development, distribution and prescribing) is significant. It can impact the opioid crisis and improve tracking drugs in the supply chain.